|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
7
|
157
|
February 11, 2026
|
|
Dichotomization
|
|
77
|
4005
|
February 8, 2026
|
|
Generalizability vs. Transportability in Trials
|
|
37
|
638
|
January 29, 2026
|
|
Oh dear - wrong interpretation on a coffee study
|
|
8
|
391
|
January 14, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
7
|
193
|
January 6, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
101
|
December 17, 2025
|
|
Randomized non-comparative trials: an oxymoron?
|
|
73
|
4409
|
December 15, 2025
|
|
Cause-Agnostic RCT (CAR)
|
|
9
|
430
|
December 12, 2025
|
|
Critique of paper on generalizability of oncology trials
|
|
27
|
2041
|
December 10, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
143
|
November 28, 2025
|
|
Omission of *absolute* risk reduction from NEJM Editorial on PSA testing
|
|
14
|
438
|
November 27, 2025
|
|
The Petty/Bone RCT
|
|
109
|
8498
|
November 22, 2025
|
|
Decades of underpowered RCT
|
|
24
|
629
|
November 20, 2025
|
|
Individual response
|
|
266
|
49006
|
November 17, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
124
|
November 11, 2025
|
|
What is a fake measurement tool and how are they used in RCT
|
|
54
|
20807
|
November 4, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
632
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
202
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
227
|
September 18, 2025
|
|
Should cSM be part of CONSORT
|
|
1
|
106
|
September 12, 2025
|
|
Sample Size Calculation for a 2x2 Factorial RCT
|
|
6
|
276
|
September 3, 2025
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
17
|
2388
|
August 4, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
201
|
May 8, 2025
|
|
Use of conditional estimands in regulatory settings
|
|
2
|
135
|
April 29, 2025
|
|
Factorial trial with interest in individual contrasts
|
|
1
|
53
|
April 26, 2025
|
|
CONSORT 2025 RCT standards document
|
|
2
|
189
|
April 25, 2025
|
|
A randomized withdrawal design
|
|
0
|
66
|
April 24, 2025
|
|
Covariate Balancing in post-hoc analysis
|
|
5
|
129
|
April 24, 2025
|
|
Missing data in repeated measures
|
|
7
|
772
|
April 15, 2025
|
|
Alpha spending/information fraction when controlling for baseline covariate
|
|
2
|
611
|
January 29, 2025
|